stella
beta
Clinical Study of SYNCAR-100 in the Treatment of Relapsed/Refractory Acute B-Lymphoblastic Leukemia — Stella
Recruiting
Back to B-Cell Acute Lymphoblastic Leukemia trials
Early Phase 1 — Very small initial tests in humans, typically just a few people, to make sure the treatment is safe enough to study further.
Trial locations
(1 site)
China
The first affiliated hospital of medical college of zhejiang university, Hangzhou, Zhejiang
View full record on ClinicalTrials.gov